Edwards Lifesciences (EW) 4: Lippis Daniel J. bought 7,850 shares of Common Stock at $N/… (May 8, 2026)

=== SEC Form 4 — Statement of Changes in Beneficial Ownership === Document Type: 4 Period of Report: 2026-05-07 10b5-1 Pre-arranged Plan: No --- Issuer --- Name: Edwards Lifesciences Corp (EW) CIK: 0001099800 --- Reporting Owner --- Name: Lippis Daniel J. CIK: 0002004380 Role: Officer (CVP, TAVR) --- Non-Derivative Transactions --- [Transaction #1] Security: Common Stock Date: 2026-05-07 | Code: A (Grant or award) Shares: +7,850 | Price: $0.00 Shares Owned After: 41,531.9103 | Ownership: D (Direct) Footnotes: [F1] These restricted stock units were granted on May 7, 2026 under the Edwards Lifesciences Corporation Long-Term Stock Incentive Compensation Program and are scheduled to become vested and exercisable commencing one year after the grant date in four equal annual installments. [Transaction #2] Security: Common Stock Date: 2026-05-07 | Code: F (Payment of exercise/tax) Shares: -309 | Price: $83.20 Total Value: $25,708.80 Shares Owned After: 41,222.9103 | Ownership: D (Direct) [Transaction #3] Security: Common Stock Date: 2026-05-08 | Code: F (Payment of exercise/tax) Shares: -450 | Price: $82.76 Total Value: $37,242.00 Shares Owned After: 40,772.9103 | Ownership: D (Direct) --- Derivative Transactions --- [Transaction #1] Security: Employee Stock Option (Right to Acquire) Date: 2026-05-07 | Code: A (Grant or award) Shares: +39,900 | Price: $0.00 Exercisable: N/A | Expires: 2033-05-06 Shares Owned After: 39,900 | Ownership: D (Direct) Footnotes: [F2] These options were granted on May 7, 2026 under the Edwards Lifesciences Corporation Long-Term Stock Incentive Compensation Program and are scheduled to become vested and exercisable commencing one year after the grant date in four equal annual installments. [Transaction #2] Security: Performance Rights Date: 2026-05-07 | Code: A (Grant or award) Shares: +7,850 | Price: $0.00 Shares Owned After: 7,850 | Ownership: D (Direct) Footnotes: [F3] Reflects the target number of shares (the Target Award) covered by restricted stock units granted on May 7, 2026 under the Edwards Lifesciences Corporation Long-Term Stock Incentive Compensation Program and are scheduled to vest on May 7, 2029. The number of restricted stock units that vest will depend upon achievement of certain performance goals over a three-year performance period and will range from 0% to 200% of the Target Awards. [F3] Reflects the target number of shares (the Target Award) covered by restricted stock units granted on May 7, 2026 under the Edwards Lifesciences Corporation Long-Term Stock Incentive Compensation Program and are scheduled to vest on May 7, 2029. The number of restricted stock units that vest will depend upon achievement of certain performance goals over a three-year performance period and will range from 0% to 200% of the Target Awards. --- Footnotes (Complete Index) --- F1: These restricted stock units were granted on May 7, 2026 under the Edwards Lifesciences Corporation Long-Term Stock Incentive Compensation Program and are scheduled to become vested and exercisable commencing one year after the grant date in four equal annual installments. F2: These options were granted on May 7, 2026 under the Edwards Lifesciences Corporation Long-Term Stock Incentive Compensation Program and are scheduled to become vested and exercisable commencing one year after the grant date in four equal annual installments. F3: Reflects the target number of shares (the Target Award) covered by restricted stock units granted on May 7, 2026 under the Edwards Lifesciences Corporation Long-Term Stock Incentive Compensation Program and are scheduled to vest on May 7, 2029. The number of restricted stock units that vest will depend upon achievement of certain performance goals over a three-year performance period and will range from 0% to 200% of the Target Awards. --- Signature --- /s/ Linda J. Park, Attorney-in-Fact (2026-05-08)